• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Menopause Strategies-Finding Lasting Answers for Symptoms and Health (MsFLASH) Investigation of Self-Reported Menopausal Palpitation Distress.一项关于自我报告的更年期心悸困扰的更年期策略——寻找症状和健康的持久答案(MsFLASH)调查。
J Womens Health (Larchmt). 2021 Apr;30(4):533-538. doi: 10.1089/jwh.2020.8586. Epub 2020 Nov 20.
2
Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials.血清雌激素浓度与绝经后妇女的绝经症状困扰有关吗?两项 MsFLASH 临床试验的基线结果。
Maturitas. 2022 Aug;162:23-30. doi: 10.1016/j.maturitas.2022.04.003. Epub 2022 Apr 25.
3
Symptom clusters among MsFLASH clinical trial participants.MsFLASH临床试验参与者中的症状群。
Menopause. 2016 Feb;23(2):158-65. doi: 10.1097/GME.0000000000000516.
4
Independent association of palpitation with vasomotor symptoms and anxiety in middle-aged women.心悸与中年女性血管舒缩症状和焦虑的独立相关性。
Menopause. 2021 May 24;28(7):741-747. doi: 10.1097/GME.0000000000001776.
5
Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials.药物和非药物干预对有热潮红女性的失眠症状和自我报告睡眠质量的影响:四项 MsFLASH 试验的个体参与者数据的汇总分析。
Sleep. 2018 Jan 1;41(1). doi: 10.1093/sleep/zsx190.
6
MsFLASH analysis of diurnal salivary cortisol and palpitations in peri- and postmenopausal women.围绝经期和绝经后妇女的日间唾液皮质醇和心悸的 MsFLASH 分析。
Menopause. 2021 Nov 29;29(2):144-150. doi: 10.1097/GME.0000000000001897.
7
Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.体重指数和绝经期间的绝经紊乱影响接受阿那曲唑治疗的绝经后日本乳腺癌患者的血管舒缩症状:一项关于患者报告结局的前瞻性多中心队列研究。
Breast Cancer. 2017 Jul;24(4):528-534. doi: 10.1007/s12282-016-0735-y. Epub 2016 Oct 12.
8
Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.基于电话的认知行为疗法对有血管舒缩症状的围绝经期和绝经后女性失眠的治疗:一项MsFLASH随机临床试验
JAMA Intern Med. 2016 Jul 1;176(7):913-20. doi: 10.1001/jamainternmed.2016.1795.
9
Lights on MsFLASH: a review of contributions.MsFLASH 之光照亮:贡献回顾。
Menopause. 2020 Apr;27(4):473-484. doi: 10.1097/GME.0000000000001461.
10
Correlations among Core Outcomes in Menopause-recommended vasomotor symptom outcomes in MsFLASH trials.围绝经期推荐的 MsFLASH 试验血管舒缩症状结局的核心结局指标间的相关性。
Menopause. 2024 Jan 1;31(1):3-9. doi: 10.1097/GME.0000000000002280. Epub 2023 Nov 13.

引用本文的文献

1
"Quick flutter skip": midlife women's descriptions of palpitations.“快速的颤动跳跃”:中年女性对心悸的描述。
Menopause. 2023 Oct 1;30(10):1014-1021. doi: 10.1097/GME.0000000000002244. Epub 2023 Aug 29.
2
Correlates of palpitations during menopause: A scoping review.绝经期心悸的相关因素:范围综述。
Womens Health (Lond). 2022 Jan-Dec;18:17455057221112267. doi: 10.1177/17455057221112267.
3
Effect of menopausal symptom treatment options on palpitations: a systematic review.更年期症状治疗方案对心悸的影响:一项系统评价
Climacteric. 2022 Apr;25(2):128-140. doi: 10.1080/13697137.2021.1948006. Epub 2021 Aug 4.
4
Review of menopausal palpitations measures.更年期心悸测量方法综述。
Womens Midlife Health. 2021 May 31;7(1):5. doi: 10.1186/s40695-021-00063-6.

本文引用的文献

1
Lights on MsFLASH: a review of contributions.MsFLASH 之光照亮:贡献回顾。
Menopause. 2020 Apr;27(4):473-484. doi: 10.1097/GME.0000000000001461.
2
Symptom clusters among MsFLASH clinical trial participants.MsFLASH临床试验参与者中的症状群。
Menopause. 2016 Feb;23(2):158-65. doi: 10.1097/GME.0000000000000516.
3
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.低剂量雌二醇与5-羟色胺-去甲肾上腺素再摄取抑制剂文拉法辛治疗血管舒缩症状的随机临床试验
JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891.
4
Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.瑜伽对血管舒缩症状的疗效:一项随机对照试验。
Menopause. 2014 Apr;21(4):339-46. doi: 10.1097/GME.0b013e31829e4baa.
5
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.ω-3治疗血管舒缩症状的疗效:一项随机对照试验。
Menopause. 2014 Apr;21(4):347-54. doi: 10.1097/GME.0b013e31829e40b8.
6
Efficacy of exercise for menopausal symptoms: a randomized controlled trial.运动对更年期症状的疗效:一项随机对照试验。
Menopause. 2014 Apr;21(4):330-8. doi: 10.1097/GME.0b013e31829e4089.
7
Symptom clusters at midlife: a four-country comparison of checklist and qualitative responses.中年症状群:四国清单和定性反应比较。
Menopause. 2012 Feb;19(2):133-44. doi: 10.1097/gme.0b013e3182292af3.
8
The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.失眠严重指数量表:用于诊断失眠病例和评估治疗反应的心理计量学指标。
Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601.
9
Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.依西酞普兰治疗健康绝经后妇女热潮红的疗效:一项随机对照试验。
JAMA. 2011 Jan 19;305(3):267-74. doi: 10.1001/jama.2010.2016.
10
Menopause symptoms in women infected with HIV: prevalence and associated factors.感染艾滋病毒女性的更年期症状:患病率及相关因素。
Gynecol Endocrinol. 2007 Apr;23(4):198-205. doi: 10.1080/09513590701253743.

一项关于自我报告的更年期心悸困扰的更年期策略——寻找症状和健康的持久答案(MsFLASH)调查。

A Menopause Strategies-Finding Lasting Answers for Symptoms and Health (MsFLASH) Investigation of Self-Reported Menopausal Palpitation Distress.

作者信息

Carpenter Janet S, Tisdale James E, Chen Chen X, Kovacs Richard, Larson Joseph C, Guthrie Katherine A, Ensrud Kristine E, Newton Katherine M, LaCroix Andrea Z

机构信息

School of Nursing, Indiana University, Indianapolis, Indiana, USA.

College of Pharmacy, Purdue University, West Lafayette, Indiana, USA.

出版信息

J Womens Health (Larchmt). 2021 Apr;30(4):533-538. doi: 10.1089/jwh.2020.8586. Epub 2020 Nov 20.

DOI:10.1089/jwh.2020.8586
PMID:33217253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064942/
Abstract

Study to describe the degree of menopausal palpitation distress and its demographic, clinical, symptom, and quality-of-life (QOL) correlates. Analysis of existing, baseline, data from peri- and postmenopausal women, 42 to 62 years of age, who participated in the Menopause Strategies-Finding Lasting Answers for Symptoms and Health (MsFLASH) clinical trials testing interventions for vasomotor symptoms ( = 759). Up to 46.8% of menopausal women report having palpitations, yet the symptom is relatively understudied. Little is known about palpitation distress or its correlates. Degree of distress from "heart racing or pounding" was self-reported over the past two weeks as "not at all," "a little bit," "moderately," "quite a bit," or "extremely." Other measures included self-report forms, clinic-verified body mass index (BMI), vasomotor symptom diaries, and validated symptom and QOL tools. The percentage who reported palpitation distress was 19.6%, 25.2%, and 33.5% in the three trials or 25.0% overall. In multivariate analysis, the odds of reporting palpitation distress was lower in past smokers (odds ratio [OR] = 0.59 [95% confidence interval (CI) 0.38-0.90]) and current smokers (OR = 0.48 [0.27-0.87]) relative to never-smokers and lower with every 5 kg/m higher BMI (OR = 0.82 [0.69-0.98]).The odds of reporting palpitation distress was higher with every five point more severe insomnia (OR = 1.28 [1.05-1.54]), five point worse depressive symptoms (OR = 1.47 [1.11-1.95]), five point worse perceived stress (OR = 1.19 [1.01-1.39]), and one point worse menopausal QOL (OR = 1.29 [1.06-1.57]). Menopausal palpitation distress is common and associated with demographic, clinical, symptom, and QOL factors. Findings can be used for screening in clinical practice and to justify additional research on this understudied symptom.

摘要

本研究旨在描述绝经后心悸困扰的程度及其与人口统计学、临床、症状和生活质量(QOL)的相关性。对年龄在42至62岁之间、参与绝经策略——寻找症状与健康的持久答案(MsFLASH)临床试验(该试验测试血管舒缩症状的干预措施,n = 759)的围绝经期和绝经后女性的现有基线数据进行分析。高达46.8%的绝经后女性报告有心悸症状,但对该症状的研究相对较少。关于心悸困扰及其相关性知之甚少。过去两周内,“心跳加速或怦怦跳”的困扰程度通过自我报告分为“完全没有”“有一点”“中等程度”“相当严重”或“极其严重”。其他测量指标包括自我报告表、经诊所核实的体重指数(BMI)、血管舒缩症状日记以及经过验证的症状和生活质量工具。在三项试验中,报告有心悸困扰的百分比分别为19.6%、25.2%和33.5%,总体为25.0%。在多变量分析中,与从不吸烟者相比,既往吸烟者(优势比[OR]=0.59[95%置信区间(CI)0.38 - 0.90])和当前吸烟者(OR = 0.48[0.27 - 0.87])报告心悸困扰的几率较低,且BMI每升高5kg/m²,几率也较低(OR = 0.82[0.69 - 0.98])。失眠每加重5分(OR = 1.28[1.05 - 1.54])、抑郁症状每加重5分(OR = 1.47[1.11 - 1.95])、感知压力每加重5分(OR = 1.19[1.01 - 1.39])以及绝经后生活质量每降低1分(OR = 1.29[1.06 - 1.57]),报告心悸困扰的几率就会更高。绝经后心悸困扰很常见,且与人口统计学、临床、症状和生活质量因素相关。研究结果可用于临床实践中的筛查,并为对这一研究较少的症状进行更多研究提供依据。